CCTG Investigational New Drug Committee Chair Dr. Bedard has a clinical practice and a research program at Princess Margaret Cancer Centre. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells. “Clinical trials are a team sport. Through CCTG, we collaborate with other cancer hospitals and industry, to innovate and deliver the best care for our patients." Research Interests: Breast cancer Germ cell cancers Clinical genomics Clinical trial design New drug development Phase 1 trials Current Publications: Full list CCTG Investigational New Drug Committee Page
